臺灣結核病實作指引, published by 衛福部疾病管制署. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/omnifhir/tb/ and changes regularly. See the Directory of published versions
Profile: 一線藥敏-Observation Drug Sensitive 1
status: Final
category: Laboratory
code: 一線藥敏報告
effective: 2026-03-10 10:45:00+0800
performer: Unnamed Organization (Healthcare Provider) (Provider number: 0401180014 (use: official))
note:
一線藥敏備註
method: Abbott RealTime MTB RIF/INH
component
code: 一線藥敏-高濃度Isoniazid
value: 敏感
component
code: 一線藥敏-低濃度Isoniazid
value: 敏感
component
code: 一線藥敏-高濃度Ethambutol
value: 敏感
component
code: 一線藥敏-低濃度Ethambutol
value: 敏感
component
code: 一線藥敏-高濃度Streptomycin
value: 敏感
component
code: 一線藥敏-低濃度Streptomycin
value: 敏感
component
code: 一線藥敏-Rifampin
value: 敏感
component
code: 一線藥敏-Pyrazinamide
value: 敏感
component
code: 其他一線藥敏
value: 敏感